168 related articles for article (PubMed ID: 29192248)
1. Hepatic Crtc2 controls whole body energy metabolism via a miR-34a-Fgf21 axis.
Han HS; Choi BH; Kim JS; Kang G; Koo SH
Nat Commun; 2017 Nov; 8(1):1878. PubMed ID: 29192248
[TBL] [Abstract][Full Text] [Related]
2. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
Han HS; Kim SG; Kim YS; Jang SH; Kwon Y; Choi D; Huh T; Moon E; Ahn E; Seong JK; Kweon HS; Hwang GS; Lee DH; Cho KW; Koo SH
Mol Metab; 2022 Jan; 55():101402. PubMed ID: 34838715
[TBL] [Abstract][Full Text] [Related]
3. Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.
Li Y; Wong K; Giles A; Jiang J; Lee JW; Adams AC; Kharitonenkov A; Yang Q; Gao B; Guarente L; Zang M
Gastroenterology; 2014 Feb; 146(2):539-49.e7. PubMed ID: 24184811
[TBL] [Abstract][Full Text] [Related]
4. Liver-enriched transcription factor CREBH interacts with peroxisome proliferator-activated receptor α to regulate metabolic hormone FGF21.
Kim H; Mendez R; Zheng Z; Chang L; Cai J; Zhang R; Zhang K
Endocrinology; 2014 Mar; 155(3):769-82. PubMed ID: 24424044
[TBL] [Abstract][Full Text] [Related]
5. CREB-upregulated lncRNA MEG3 promotes hepatic gluconeogenesis by regulating miR-302a-3p-CRTC2 axis.
Zhu X; Li H; Wu Y; Zhou J; Yang G; Wang W; Kang D; Ye S
J Cell Biochem; 2019 Mar; 120(3):4192-4202. PubMed ID: 30260029
[TBL] [Abstract][Full Text] [Related]
6. Adropin regulates hepatic glucose production via PP2A/AMPK pathway in insulin-resistant hepatocytes.
Chen X; Chen S; Shen T; Yang W; Chen Q; Zhang P; You Y; Sun X; Xu H; Tang Y; Mi J; Yang Y; Ling W
FASEB J; 2020 Aug; 34(8):10056-10072. PubMed ID: 32579277
[TBL] [Abstract][Full Text] [Related]
7. Role of CRTC2 in Metabolic Homeostasis: Key Regulator of Whole-Body Energy Metabolism?
Han HS; Kwon Y; Koo SH
Diabetes Metab J; 2020 Aug; 44(4):498-508. PubMed ID: 32174060
[TBL] [Abstract][Full Text] [Related]
8. Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease.
Ding J; Li M; Wan X; Jin X; Chen S; Yu C; Li Y
Sci Rep; 2015 Sep; 5():13729. PubMed ID: 26330104
[TBL] [Abstract][Full Text] [Related]
9. Hepatic Sam68 Regulates Systemic Glucose Homeostasis and Insulin Sensitivity.
Qiao A; Ma W; Jiang Y; Han C; Yan B; Zhou J; Qin G
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232770
[TBL] [Abstract][Full Text] [Related]
10. A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange.
Liu Y; Dentin R; Chen D; Hedrick S; Ravnskjaer K; Schenk S; Milne J; Meyers DJ; Cole P; Yates J; Olefsky J; Guarente L; Montminy M
Nature; 2008 Nov; 456(7219):269-73. PubMed ID: 18849969
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-CREB/CRTC2 signaling cascade regulates hepatic BMAL1 protein.
Sun X; Dang F; Zhang D; Yuan Y; Zhang C; Wu Y; Wang Y; Liu Y
J Biol Chem; 2015 Jan; 290(4):2189-97. PubMed ID: 25480789
[TBL] [Abstract][Full Text] [Related]
12. MiR-34a regulates mitochondrial content and fat ectopic deposition induced by resistin through the AMPK/PPARα pathway in HepG2 cells.
Wen F; An C; Wu X; Yang Y; Xu J; Liu Y; Wang C; Nie L; Fang H; Yang Z
Int J Biochem Cell Biol; 2018 Jan; 94():133-145. PubMed ID: 29197627
[TBL] [Abstract][Full Text] [Related]
13. Thyroid stimulating hormone increases hepatic gluconeogenesis via CRTC2.
Li Y; Wang L; Zhou L; Song Y; Ma S; Yu C; Zhao J; Xu C; Gao L
Mol Cell Endocrinol; 2017 May; 446():70-80. PubMed ID: 28212844
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity.
Nixon M; Stewart-Fitzgibbon R; Fu J; Akhmedov D; Rajendran K; Mendoza-Rodriguez MG; Rivera-Molina YA; Gibson M; Berglund ED; Justice NJ; Berdeaux R
Mol Metab; 2016 Jan; 5(1):34-46. PubMed ID: 26844205
[TBL] [Abstract][Full Text] [Related]
15. Hepatic CREB3L3 controls whole-body energy homeostasis and improves obesity and diabetes.
Nakagawa Y; Satoh A; Yabe S; Furusawa M; Tokushige N; Tezuka H; Mikami M; Iwata W; Shingyouchi A; Matsuzaka T; Kiwata S; Fujimoto Y; Shimizu H; Danno H; Yamamoto T; Ishii K; Karasawa T; Takeuchi Y; Iwasaki H; Shimada M; Kawakami Y; Urayama O; Sone H; Takekoshi K; Kobayashi K; Yatoh S; Takahashi A; Yahagi N; Suzuki H; Yamada N; Shimano H
Endocrinology; 2014 Dec; 155(12):4706-19. PubMed ID: 25233440
[TBL] [Abstract][Full Text] [Related]
16. Arginine methylation of CRTC2 is critical in the transcriptional control of hepatic glucose metabolism.
Han HS; Jung CY; Yoon YS; Choi S; Choi D; Kang G; Park KG; Kim ST; Koo SH
Sci Signal; 2014 Feb; 7(314):ra19. PubMed ID: 24570487
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
18. Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21.
Camporez JP; Asrih M; Zhang D; Kahn M; Samuel VT; Jurczak MJ; Jornayvaz FR
J Endocrinol; 2015 Sep; 226(3):207-17. PubMed ID: 26203166
[TBL] [Abstract][Full Text] [Related]
19. PPARalpha is a key regulator of hepatic FGF21.
Lundåsen T; Hunt MC; Nilsson LM; Sanyal S; Angelin B; Alexson SE; Rudling M
Biochem Biophys Res Commun; 2007 Aug; 360(2):437-40. PubMed ID: 17601491
[TBL] [Abstract][Full Text] [Related]
20. Astragalus polysaccharides affect insulin resistance by regulating the hepatic SIRT1-PGC-1α/PPARα-FGF21 signaling pathway in male Sprague Dawley rats undergoing catch-up growth.
Gu C; Zeng Y; Tang Z; Wang C; He Y; Feng X; Zhou L
Mol Med Rep; 2015 Nov; 12(5):6451-60. PubMed ID: 26323321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
